$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
恩杂鲁胺一般多久才会耐药?
2025-10-19 11:44:20
Check Details
恩杂鲁胺要多少钱?
2025-10-19 11:44:20
Check Details
阿比特龙无效后怎么处理?
2025-10-19 11:44:20
Check Details
恩杂鲁胺详细说明书
2025-10-19 11:44:20
Check Details
恩杂鲁胺中国上市了吗?
2025-10-19 11:44:20
Check Details
吃阿比特龙多久会耐药?
2025-10-19 11:44:20
Check Details
恩杂鲁胺是治什么的药品?
2025-10-19 11:44:20
Check Details
恩杂鲁胺是什么东西?
2025-10-19 11:44:20
Check Details
阿比特龙能够吃多长时间?
2025-10-19 11:44:20
Check Details
恩杂鲁胺最新的价格是多少?
2025-10-19 11:44:20
Check Details
恩杂鲁胺服用多久病情会好转?
2025-10-19 11:44:20
Check Details
恩杂鲁胺吃几天会见效?
2025-10-19 11:44:20
Check Details
1
2
...
1325
1326
1327
1328
1329
1330
1331
...
4161
4162
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Zenocutuzumab (Bizengri) for NRG1 Fusion Solid Tumors: HER2×HER3 Bispecific, 750mg Q2W, NSCLC/Pancreas/Cholangiocarcinoma
2
Pemigatinib for FGFR2 Cholangiocarcinoma and FGFR1 Hematologic Use: First-Line Data, 21-Day Dosing, Phosphate and Ocular Management
3
Dabrafenib (Tafinlar) Complete Guide: Indications, Dosing, Combination Therapy and Safety
4
Binimetinib plus Encorafenib for BRAF‑Mutant Melanoma
5
Adagrasib (Krazati) for KRAS G12C: NSCLC Dosing, Titration, and CRC Regulatory Update
6
Ceritinib for ALK-Positive NSCLC: Indication, Dosing, and Safety Management
7
Enzalutamide for Prostate Cancer: Managing Fatigue, Dizziness, Hypertension, and Serious Neurocardiovascular Risks
8
Tamoxifen Long-Term Safety: Vigilance for Thrombosis and Endometrial Risks
9
Acoramidis for ATTR-CM: Disease Progression Is Not Equivalent to Drug Resistance
10
Lorlatinib Contraindications and Safety Warnings: Six Key Risks to Monitor
11
Dacomitinib for EGFR-Mutant NSCLC: Dosing, Switching, and Safety Profile
12
Abemaciclib for HR+ HER2- Breast Cancer: Mechanism, Combination Therapy, and Switching Considerations